Global Melanoma Drugs Market Size, Status and Forecast 2025

March 2018 | 108 pages | ID: GCD644D3865QEN
QYResearch

Abstracts

This report studies the global Melanoma Drugs market, analyzes and researches the Melanoma Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Bristol-Myers Squibb
• Enzon Pharmaceuticals
• Exelixis
• GlaxoSmithKline
• Merck
• Pfizer
• Janssen Biotech
• Hoffmann-La Roche Ltd
• Navidea Biopharmaceuticals
• Novartis
• Ono Pharmaceutical
• Amgen

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Immunotherapy
• Targeted Therapy
• Other

Market segment by Application, Melanoma Drugs can be split into

• Hospitals
• Clinics
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Melanoma Drugs Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF MELANOMA DRUGS

1.1 Melanoma Drugs Market Overview
  1.1.1 Melanoma Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Melanoma Drugs Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Melanoma Drugs Market by Type
  1.3.1 Immunotherapy
  1.3.2 Targeted Therapy
  1.3.3 Other
1.4 Melanoma Drugs Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Clinics
  1.4.3 Other

2 GLOBAL MELANOMA DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Melanoma Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Bristol-Myers Squibb
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Enzon Pharmaceuticals
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Exelixis
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 GlaxoSmithKline
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Merck
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Pfizer
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Janssen Biotech
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 Hoffmann-La Roche Ltd
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments
3.9 Navidea Biopharmaceuticals
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.9.5 Recent Developments
3.10 Novartis
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Melanoma Drugs Revenue (Million USD) (2013-2018)
  3.10.5 Recent Developments
3.11 Ono Pharmaceutical
3.12 Amgen

4 GLOBAL MELANOMA DRUGS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Melanoma Drugs Market Size by Type (2013-2018)
4.2 Global Melanoma Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Melanoma Drugs in Future
4.4 Top Consumer/End Users of Melanoma Drugs

5 UNITED STATES MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Melanoma Drugs Market Size (2013-2018)
5.2 United States Melanoma Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Melanoma Drugs Market Size by Application (2013-2018)

6 EU MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Melanoma Drugs Market Size (2013-2018)
6.2 EU Melanoma Drugs Market Size and Market Share by Players (2013-2018)
6.3 EU Melanoma Drugs Market Size by Application (2013-2018)

7 JAPAN MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Melanoma Drugs Market Size (2013-2018)
7.2 Japan Melanoma Drugs Market Size and Market Share by Players (2013-2018)
7.3 Japan Melanoma Drugs Market Size by Application (2013-2018)

8 CHINA MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Melanoma Drugs Market Size (2013-2018)
8.2 China Melanoma Drugs Market Size and Market Share by Players (2013-2018)
8.3 China Melanoma Drugs Market Size by Application (2013-2018)

9 INDIA MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Melanoma Drugs Market Size (2013-2018)
9.2 India Melanoma Drugs Market Size and Market Share by Players (2013-2018)
9.3 India Melanoma Drugs Market Size by Application (2013-2018)

10 SOUTHEAST ASIA MELANOMA DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Melanoma Drugs Market Size (2013-2018)
10.2 Southeast Asia Melanoma Drugs Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Melanoma Drugs Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Melanoma Drugs Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Melanoma Drugs Revenue and Growth Rate (2018-2025)
  11.1.2 EU Melanoma Drugs Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Melanoma Drugs Revenue and Growth Rate (2018-2025)
  11.1.4 China Melanoma Drugs Revenue and Growth Rate (2018-2025)
  11.1.5 India Melanoma Drugs Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Melanoma Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Melanoma Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Melanoma Drugs Market Size by Application (2018-2025)

12 MELANOMA DRUGS MARKET DYNAMICS

12.1 Melanoma Drugs Market Opportunities
12.2 Melanoma Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Melanoma Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Melanoma Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Melanoma Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Melanoma Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Melanoma Drugs Market Share by Regions (2013-2018)
Figure United States Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Melanoma Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Melanoma Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Melanoma Drugs Revenue Market Share by Type in 2017
Figure Immunotherapy Market Size (Million USD) and Growth Rate (2013-2018)
Figure Targeted Therapy Market Size (Million USD) and Growth Rate (2013-2018)
Figure Other Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Melanoma Drugs Market Share by Application in 2017
Figure Melanoma Drugs Market Size (Million USD) and Growth Rate in Hospitals (2013-2018)
Figure Melanoma Drugs Market Size (Million USD) and Growth Rate in Clinics (2013-2018)
Figure Melanoma Drugs Market Size (Million USD) and Growth Rate in Other (2013-2018)
Table Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure Melanoma Drugs Market Size Share by Players in 2013
Figure Melanoma Drugs Market Size Share by Players in 2017
Table Bristol-Myers Squibb Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)
Figure Bristol-Myers Squibb Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Enzon Pharmaceuticals Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Enzon Pharmaceuticals (2013-2018)
Figure Enzon Pharmaceuticals Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Exelixis Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Exelixis (2013-2018)
Figure Exelixis Melanoma Drugs Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Merck Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Janssen Biotech Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Janssen Biotech (2013-2018)
Figure Janssen Biotech Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Hoffmann-La Roche Ltd Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Hoffmann-La Roche Ltd (2013-2018)
Figure Hoffmann-La Roche Ltd Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Navidea Biopharmaceuticals Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Navidea Biopharmaceuticals (2013-2018)
Figure Navidea Biopharmaceuticals Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Novartis Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Novartis (2013-2018)
Figure Novartis Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Ono Pharmaceutical Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Ono Pharmaceutical (2013-2018)
Figure Ono Pharmaceutical Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Amgen Basic Information List
Table Melanoma Drugs Business Revenue (Million USD) of Amgen (2013-2018)
Figure Amgen Melanoma Drugs Business Revenue Market Share (2013-2018)
Table Global Melanoma Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Melanoma Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Melanoma Drugs Market Share by Product in 2017
Table Global Melanoma Drugs Market Size by Application (2013-2018)
Figure Global Melanoma Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Melanoma Drugs
Figure United States Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Melanoma Drugs Market Size Share by Players in 2013
Figure United States Melanoma Drugs Market Size Share by Players in 2017
Table United States Melanoma Drugs Market Size by Application (2013-2018)
Figure United States Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Melanoma Drugs Market Size Share by Application in 2017
Figure EU Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure EU Melanoma Drugs Market Size Share by Players in 2013
Figure EU Melanoma Drugs Market Size Share by Players in 2017
Table EU Melanoma Drugs Market Size by Application (2013-2018)
Figure EU Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure EU Melanoma Drugs Market Size Share by Application in 2017
Figure Japan Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Melanoma Drugs Market Size Share by Players in 2013
Figure Japan Melanoma Drugs Market Size Share by Players in 2017
Table Japan Melanoma Drugs Market Size by Application (2013-2018)
Figure Japan Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Melanoma Drugs Market Size Share by Application in 2017
Figure China Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Melanoma Drugs Market Size Share by Players in 2013
Figure China Melanoma Drugs Market Size Share by Players in 2017
Table China Melanoma Drugs Market Size by Application (2013-2018)
Figure China Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Melanoma Drugs Market Size Share by Application in 2017
Figure India Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Melanoma Drugs Market Size Share by Players in 2013
Figure India Melanoma Drugs Market Size Share by Players in 2017
Table India Melanoma Drugs Market Size by Application (2013-2018)
Figure India Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Melanoma Drugs Market Size Share by Application in 2017
Figure Southeast Asia Melanoma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Melanoma Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Melanoma Drugs Market Size Share by Players in 2013
Figure Southeast Asia Melanoma Drugs Market Size Share by Players in 2017
Table Southeast Asia Melanoma Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Melanoma Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Melanoma Drugs Market Size Share by Application in 2017
Figure Global Melanoma Drugs Market Size and Growth Rate (2018-2025)
Table Global Melanoma Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Melanoma Drugs Market Size Share (2018-2025)
Figure Global Melanoma Drugs Market Size Share by Regions in 2025
Figure United States Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Melanoma Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Melanoma Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Melanoma Drugs Market Size Share by Type in 2018
Figure Global Melanoma Drugs Market Size Share by Type in 2025
Table Global Melanoma Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Melanoma Drugs Market Size (Million USD) by Application in 2018
Figure Global Melanoma Drugs Market Size (Million USD) by Application in 2025